BioImpact Capital LLC, 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 35,990 shares at $27.00 ($972K) on 2021-09-28, disclosed to the SEC on 2021-09-30.
Open-market sale of $972k ITOS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.00 | 32,154 | $868K | 89.3% |
| 2 | $27.00 | 3,836 | $104K | 10.7% |
| Total | $27.00 avg | 35,990 | $972K | 100% |
| Filing → |
| CGEM | SELL | 2021-09-16 | $602K | — | Filing → |
| CGEM | SELL | 2021-09-13 | $1.4M | — | Filing → |
| ITOS | SELL | 2021-09-13 | $5.5M | — | Filing → |